Blood ketone meters are medical devices used to measure ketone levels in blood samples. These meters help in monitoring ketone levels in blood, especially useful for diabetics and those following ketogenic diets. The growing diabetes prevalence globally has increased the demand for blood ketone monitoring to manage the risks associated with ketosis.

The global blood ketone meter market is estimated to be valued at US$ 365.8 Mn in 2023 and is expected to exhibit a CAGR of 6.9% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.

Market Opportunity:

The increasing prevalence of diabetes has opened growth opportunities for the blood ketone meter market size. As per the International Diabetes Federation (IDF), approximately 537 million adults aged 20-79 years were living with diabetes in 2021 across the globe. This number is projected to reach 643 million by 2030 and 778 million by 2045. Monitoring ketone levels is important for diabetic patients to detect diabetic ketoacidosis, a serious complication of diabetes. Using blood ketone meters help in early diagnosis and treatment of hyperketonemia, saving lives. Moreover, the growing popularity of the ketogenic diet has also boosted the demand for ketone testing. The rising cases of diabetes, coupled with shifting consumer preference towards low-carb keto diets present lucrative opportunities for players in the blood ketone meter market to tap into this demand.

Porter’s Analysis

Threat of new entrants: Low due to the presence of stringent regulatory requirements for manufacturing blood ketone meters and test strips. New entrants require huge capital investments to acquire the necessary technological expertise, manufacturing facilities, and distribution channels.

Bargaining power of buyers: Moderate as several manufacturers offer a variety of blood ketone meters. However, buyers have high bargaining power due to the availability of alternative technologies such as urine testing.

Bargaining power of suppliers: Moderate as there are many suppliers for various components such as sensors, chips, casing materials. However, some suppliers possess proprietary technologies for critical components exerting bargaining power.

Threat of new substitutes: Low as blood ketone testing represents an accurate, convenient method over urine testing. Alternative non-invasive technologies are in nascent stages.

Competitive rivalry: High due to the presence of numerous global and regional players offering low-cost products. Players compete based on product features, reliability, pricing, and market reach.

SWOT Analysis
Strengths: Accurate measurement of ketone levels. Convenient usage with increasing adoption among diabetes and keto dieters.

Weaknesses: Relatively high product and test strip costs. Require painful finger pricks.

Opportunities: Expanding diabetic and ketogenic diet demographics. Developing economies present growth prospects.

Threats: Strict regulatory norms. Threat from non-invasive technologies. Intense competition and pricing pressures.

Key Takeaways

The global blood ketone meter market is expected to witness high growth over the forecast period owing to the rising diabetic population globally and growing popularity of the ketogenic diet. The global Blood Ketone Meter Market is estimated to be valued at US$ 365.8 Mn in 2023 and is expected to exhibit a CAGR of 6.9% over the forecast period 2023 to 2030.

Regionally, North America currently dominates the blood ketone meter market and is expected to maintain its lead till 2030 due to the increasing obesity rates and greater awareness about diabetes and low-carb diets in the US and Canada. Asia Pacific is projected to be the fastest growing market during the forecast period with China and India emerging as major hubs for production and sales of blood ketone meters.

Key players operating in the blood ketone meter market are Abbott Laboratories, ACON Laboratories Inc., Nipro Corporation, Keto-Mojo, PortaCheck Inc., Nova Biomedical, GlucoRx Limited, EKF Diagnostics Holdings Plc., Taidoc Technology Corporation, ForaCare Inc., Bruno MD, and Apex Biotechnology Corporation. Abbott Laboratories holds the leading market share with its reliable Precision Xtra Blood Glucose and Ketone Monitoring System being the preferred choice of medical professionals and patients globally.

Get more insights on this topic: https://creativenewsalert.weebly.com/blog/blood-ketone-meter-market-poised-for-significant-growth-owing-to-increasing-prevalence-of-diabetes